NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|675510779|ref|YP_009054977|]
View 

envelope glycoprotein I [Equid alphaherpesvirus 3]

Protein Classification

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
PHA03292 super family cl30052
envelope glycoprotein I; Provisional
24-447 1.38e-109

envelope glycoprotein I; Provisional


The actual alignment was detected with superfamily member PHA03292:

Pssm-ID: 177577  Cd Length: 413  Bit Score: 329.61  E-value: 1.38e-109
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779  24 IIYRGAHVSMYLNASSEFAVHPTDERLEIAGHLLFLKDQRLPVNNYSGVVEVIYYNYTNLCYRVLQTIEYESCPRVANNA 103
Cdd:PHA03292  23 IVYRGEHVSLYLDASSEFAVYPTDASLVLVGHLIFLDGQRLPTTNYNGTIELIHYNYSSDCYVVIQTISYESCPRVANNA 102
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779 104 FRSCLHKVSRHHHgDPLRVNVSVETNVLLHIAQPQPSDSGLYVLRVRFGHNAAADVFGVYAFVYDFGAARGEGEGNGTlt 183
Cdd:PHA03292 103 FRSCLHKTSRHNR-DYFRVNASVETNVLLNITGPQPADSGAYILRVKLDHAPTADVFGLSAFVYDFDSPTVPDPEPTT-- 179
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779 184 ptpaPPSDPPSAPATPTPKATPTAAATEAKNGSAATF----IATPAPPSAAALAQLLTAADPTVQVGGDRIPCRFFAQGP 259
Cdd:PHA03292 180 ----ARPEPAAGYVATPTPRYLNAVTTSTYSRSMSSQpagaATATPTPTLDTGLTTVAPPNETVVTGETALLCHWFQPST 255
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779 260 GSPTFFMHLLGIEGNMTDDYAMEEDGAGGSSASAKASATGGAATTTTTAPPTTPPAnatvnsKAHSKVLALVVIPTACIL 339
Cdd:PHA03292 256 RVPTLYLHLLGTTGNLTEDVLLTEDSEILRTPPPDPSSSRSPGAGDDFKQTNSTSP------KRRNKIVAMIVIPTACVV 329
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779 340 LLLLLVVGAIINNAVRRHLIGCASRRIYRPGSGLGPGTaaELATLARSPavgasseslaseaaaaaaaasAPPKRNGAS- 418
Cdd:PHA03292 330 LLLLAVVGAIINGAVRKHLLSCASRRIYRPRQGGASSS--ERRRLTCGP---------------------TPAASSESLa 386
                        410       420       430
                 ....*....|....*....|....*....|
gi 675510779 419 -RSGASKPGQPPDpfmEQLSRKLESIKEES 447
Cdd:PHA03292 387 dDTTVSPPSSKPK---AKPKRKLEAIKEES 413
 
Name Accession Description Interval E-value
PHA03292 PHA03292
envelope glycoprotein I; Provisional
24-447 1.38e-109

envelope glycoprotein I; Provisional


Pssm-ID: 177577  Cd Length: 413  Bit Score: 329.61  E-value: 1.38e-109
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779  24 IIYRGAHVSMYLNASSEFAVHPTDERLEIAGHLLFLKDQRLPVNNYSGVVEVIYYNYTNLCYRVLQTIEYESCPRVANNA 103
Cdd:PHA03292  23 IVYRGEHVSLYLDASSEFAVYPTDASLVLVGHLIFLDGQRLPTTNYNGTIELIHYNYSSDCYVVIQTISYESCPRVANNA 102
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779 104 FRSCLHKVSRHHHgDPLRVNVSVETNVLLHIAQPQPSDSGLYVLRVRFGHNAAADVFGVYAFVYDFGAARGEGEGNGTlt 183
Cdd:PHA03292 103 FRSCLHKTSRHNR-DYFRVNASVETNVLLNITGPQPADSGAYILRVKLDHAPTADVFGLSAFVYDFDSPTVPDPEPTT-- 179
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779 184 ptpaPPSDPPSAPATPTPKATPTAAATEAKNGSAATF----IATPAPPSAAALAQLLTAADPTVQVGGDRIPCRFFAQGP 259
Cdd:PHA03292 180 ----ARPEPAAGYVATPTPRYLNAVTTSTYSRSMSSQpagaATATPTPTLDTGLTTVAPPNETVVTGETALLCHWFQPST 255
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779 260 GSPTFFMHLLGIEGNMTDDYAMEEDGAGGSSASAKASATGGAATTTTTAPPTTPPAnatvnsKAHSKVLALVVIPTACIL 339
Cdd:PHA03292 256 RVPTLYLHLLGTTGNLTEDVLLTEDSEILRTPPPDPSSSRSPGAGDDFKQTNSTSP------KRRNKIVAMIVIPTACVV 329
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779 340 LLLLLVVGAIINNAVRRHLIGCASRRIYRPGSGLGPGTaaELATLARSPavgasseslaseaaaaaaaasAPPKRNGAS- 418
Cdd:PHA03292 330 LLLLAVVGAIINGAVRKHLLSCASRRIYRPRQGGASSS--ERRRLTCGP---------------------TPAASSESLa 386
                        410       420       430
                 ....*....|....*....|....*....|
gi 675510779 419 -RSGASKPGQPPDpfmEQLSRKLESIKEES 447
Cdd:PHA03292 387 dDTTVSPPSSKPK---AKPKRKLEAIKEES 413
Herpes_gI pfam01688
Alphaherpesvirus glycoprotein I; This family consists of glycoprotein I form various members ...
24-160 2.79e-25

Alphaherpesvirus glycoprotein I; This family consists of glycoprotein I form various members of the alphaherpesvirinae these include herpesvirus, varicella-zoster virus and pseudorabies virus. Glycoprotein I (gI) is important during natural infection, mutants lacking gI produce smaller lesions at the site of infection and show reduced neuronal spread. gI forms a heterodimeric complex with gE; this complex displays Fc receptor activity (binds to the Fc region of immunoglobulin). Glycoproteins are also important in the production of virus-neutralising antibodies and cell mediated immunity. The alphaherpesvirinae have a dsDNA gnome and have no RNA stage during viral replication.


Pssm-ID: 279953  Cd Length: 155  Bit Score: 101.05  E-value: 2.79e-25
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779   24 IIYRGAHVSMYLNASSEFAVHPTD--ERLEIAGHLLFLKDQRLPVNNYSGVVEVIYYNYTNLCYRVLQTIEYESCPRVAN 101
Cdd:pfam01688  15 LVVKGPTVSLVSDSSLDVGACGPDkvVEEDVGGQLVFLGDQVPTTNYYDGTVELLHYPEGGKCPRVVHVVRYTACPRIPA 94
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 675510779  102 NAFRSCLHKVSRHHHGDPLRVNVSVEtnvLLHIAQPQPSDSGLYVLRVRFGHNAAADVF 160
Cdd:pfam01688  95 VAFSGCRRTDSEHYPTPEDRLATQPG---LLRIRTPTRDDAGVYVLRVWLDHAPNADAF 150
 
Name Accession Description Interval E-value
PHA03292 PHA03292
envelope glycoprotein I; Provisional
24-447 1.38e-109

envelope glycoprotein I; Provisional


Pssm-ID: 177577  Cd Length: 413  Bit Score: 329.61  E-value: 1.38e-109
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779  24 IIYRGAHVSMYLNASSEFAVHPTDERLEIAGHLLFLKDQRLPVNNYSGVVEVIYYNYTNLCYRVLQTIEYESCPRVANNA 103
Cdd:PHA03292  23 IVYRGEHVSLYLDASSEFAVYPTDASLVLVGHLIFLDGQRLPTTNYNGTIELIHYNYSSDCYVVIQTISYESCPRVANNA 102
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779 104 FRSCLHKVSRHHHgDPLRVNVSVETNVLLHIAQPQPSDSGLYVLRVRFGHNAAADVFGVYAFVYDFGAARGEGEGNGTlt 183
Cdd:PHA03292 103 FRSCLHKTSRHNR-DYFRVNASVETNVLLNITGPQPADSGAYILRVKLDHAPTADVFGLSAFVYDFDSPTVPDPEPTT-- 179
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779 184 ptpaPPSDPPSAPATPTPKATPTAAATEAKNGSAATF----IATPAPPSAAALAQLLTAADPTVQVGGDRIPCRFFAQGP 259
Cdd:PHA03292 180 ----ARPEPAAGYVATPTPRYLNAVTTSTYSRSMSSQpagaATATPTPTLDTGLTTVAPPNETVVTGETALLCHWFQPST 255
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779 260 GSPTFFMHLLGIEGNMTDDYAMEEDGAGGSSASAKASATGGAATTTTTAPPTTPPAnatvnsKAHSKVLALVVIPTACIL 339
Cdd:PHA03292 256 RVPTLYLHLLGTTGNLTEDVLLTEDSEILRTPPPDPSSSRSPGAGDDFKQTNSTSP------KRRNKIVAMIVIPTACVV 329
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779 340 LLLLLVVGAIINNAVRRHLIGCASRRIYRPGSGLGPGTaaELATLARSPavgasseslaseaaaaaaaasAPPKRNGAS- 418
Cdd:PHA03292 330 LLLLAVVGAIINGAVRKHLLSCASRRIYRPRQGGASSS--ERRRLTCGP---------------------TPAASSESLa 386
                        410       420       430
                 ....*....|....*....|....*....|
gi 675510779 419 -RSGASKPGQPPDpfmEQLSRKLESIKEES 447
Cdd:PHA03292 387 dDTTVSPPSSKPK---AKPKRKLEAIKEES 413
PHA03290 PHA03290
envelope glycoprotein I; Provisional
24-167 1.02e-27

envelope glycoprotein I; Provisional


Pssm-ID: 165547  Cd Length: 357  Bit Score: 113.19  E-value: 1.02e-27
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779  24 IIYRGAHVSMYLNAS--SEFAVHPTDERLEIAGHLLFLKDQrLPV-NNYSGVVEVIYYNYTNLCYRVLQTIEYESCPRVA 100
Cdd:PHA03290  21 IIFKGDHISLQVNSSatSIFIKMGNDNDAEIKGQFLFIGDQ-FPTgNNYNGTLELLHADQTAFCFQPLQRIMYDECPRIR 99
                         90       100       110       120       130       140
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 675510779 101 NNAFRSCLHKVSRHHHGDPLRVNVSVETNVLLHIAQPQPSDSGLYVLRVRFGHNAAADVFGVYAFVY 167
Cdd:PHA03290 100 TGAFIACRVKHSWHYENATDRILTDPDAEIIFKINKPGIEDAGIYLLLVQLDHSRLFDGFFLGLNVY 166
Herpes_gI pfam01688
Alphaherpesvirus glycoprotein I; This family consists of glycoprotein I form various members ...
24-160 2.79e-25

Alphaherpesvirus glycoprotein I; This family consists of glycoprotein I form various members of the alphaherpesvirinae these include herpesvirus, varicella-zoster virus and pseudorabies virus. Glycoprotein I (gI) is important during natural infection, mutants lacking gI produce smaller lesions at the site of infection and show reduced neuronal spread. gI forms a heterodimeric complex with gE; this complex displays Fc receptor activity (binds to the Fc region of immunoglobulin). Glycoproteins are also important in the production of virus-neutralising antibodies and cell mediated immunity. The alphaherpesvirinae have a dsDNA gnome and have no RNA stage during viral replication.


Pssm-ID: 279953  Cd Length: 155  Bit Score: 101.05  E-value: 2.79e-25
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779   24 IIYRGAHVSMYLNASSEFAVHPTD--ERLEIAGHLLFLKDQRLPVNNYSGVVEVIYYNYTNLCYRVLQTIEYESCPRVAN 101
Cdd:pfam01688  15 LVVKGPTVSLVSDSSLDVGACGPDkvVEEDVGGQLVFLGDQVPTTNYYDGTVELLHYPEGGKCPRVVHVVRYTACPRIPA 94
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 675510779  102 NAFRSCLHKVSRHHHGDPLRVNVSVEtnvLLHIAQPQPSDSGLYVLRVRFGHNAAADVF 160
Cdd:pfam01688  95 VAFSGCRRTDSEHYPTPEDRLATQPG---LLRIRTPTRDDAGVYVLRVWLDHAPNADAF 150
PHA03289 PHA03289
envelope glycoprotein I; Provisional
24-166 3.83e-17

envelope glycoprotein I; Provisional


Pssm-ID: 165546  Cd Length: 352  Bit Score: 82.27  E-value: 3.83e-17
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 675510779  24 IIYRGAHVSMYLNASSEFAVHPTDERLEIAGHLLFLKDQRLpVNNYSGVVEVIYYNYTNLCYRVLQTIEYESCPRVANNA 103
Cdd:PHA03289  19 MVYTGTSVSTSTDQSAQVAFCGLDKVVNVYGKLLFLGDQYL-EESYSGTTEILKWNEANKCYSVAHATYYADCPIISSTV 97
                         90       100       110       120       130       140
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 675510779 104 FRSCLHKV--SRHHHgdplRVNVSVETNVLLHIAQPQPSDSGLYVLRVRFGHNAAADVFGVYAFV 166
Cdd:PHA03289  98 FRGCRDAVvyARPHD----RVHPQYEKGLLLTIIEPRMSDTGIYYIRVSLAGRNKSDIFRTSVFV 158
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH